VERA

NASDAQ 已收盘

Vera Therapeutics

26.75 USD
▲+1.17+4.57%
盘后 26.23 -1.94%
2026-11-19
市值
$1.84B
市盈率
—
EPS
-5.91
股息率
—
52 周区间
25.08 – 56.05
成交量
1.05M
Beta
1.19
目标价
71.36
52W 低 25.0852W 高 56.05
价格走势

公司简介

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a ...